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ABSTRACT
Objectives: Childhood asthma is a complex condition
where many environmental factors are implicated in
causation. The aim of this study was to complete a
systematic review of the literature describing
associations between environmental exposures and the
development of asthma in young children.
Setting: A systematic review of the literature up to
November 2013 was conducted using key words
agreed by the research team. Abstracts were screened
and potentially eligible papers reviewed. Papers
describing associations between exposures and
exacerbation of pre-existing asthma were not included.
Papers were placed into the following predefined
categories: secondhand smoke (SHS), inhaled
chemicals, damp housing/mould, inhaled allergens, air
pollution, domestic combustion, dietary exposures,
respiratory virus infection and medications.
Participants: Children aged up to 9 years.
Primary outcomes: Diagnosed asthma and wheeze.
Results: 14 691 abstracts were identified, 207 papers
reviewed and 135 included in the present review of
which 15 were systematic reviews, 6 were meta-
analyses and 14 were intervention studies. There was
consistent evidence linking exposures to SHS, inhaled
chemicals, mould, ambient air pollutants, some
deficiencies in maternal diet and respiratory viruses to
an increased risk for asthma (OR typically increased by
1.5–2.0). There was less consistent evidence linking
exposures to pets, breast feeding and infant dietary
exposures to asthma risk, and although there were
consistent associations between exposures to
antibiotics and paracetamol in early life, these
associations might reflect reverse causation. There was
good evidence that exposures to house dust mites (in
isolation) was not associated with asthma risk.
Evidence from observational and intervention studies
suggest that interactions between exposures were
important to asthma causation, where the effect size
was typically 1.5–3.0.
Conclusions: There are many publications reporting
associations between environmental exposures and
modest changes in risk for asthma in young children,
and this review highlights the complex interactions
between exposures that further increase risk.
INTRODUCTION
Asthma is a common chronic condition in
children where environmental and genetic
factors are implicated in causation. The
rapid rise in asthma during the 1980s and
1990s1 was too abrupt to be explained solely
by change in prevalence of genetic varia-
tions. Changing environmental exposures
appear to be relevant to the high prevalence
of asthma in the Western world,2 although
some exposures are likely to be effective via
epigenetic mechanisms.3
Many environmental exposures have been
linked to asthma causation, including aller-
gens,4 smoking,5 dietary factors6 and respira-
tory infections.7 Recently, evidence has
emerged to suggest that asthma causation may
involve interactions between different environ-
mental exposures8 9 and/or environmental
exposures and atopy.10 Owing to the many
challenges of relating even a single exposure
to asthma causation, there is very little synthe-
sis in the literature of multiple environmental
exposures and asthma causation.
The Environmental Determinants of Public
Health in Scotland (EDPHiS) was commis-
sioned in 2009 to quantify the evidence on the
connections between the environment and
Strengths and limitations of this study
▪ This is the first systematic review of the whole
literature relating early life environmental expo-
sures to childhood asthma causation.
▪ A high level of evidence was available (ie, sys-
tematic reviews, meta-analyses and/or interven-
tion studies) for many exposure classes.
▪ More than 70% of papers identified described
associations observed within single populations.
▪ The observational literature is likely to be affected by
publication bias, reverse causation and confounders.
▪ Studies describing outcomes in children where
the mean age was >9 years were not included.
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key aspects of health of children in order to inform the
development of public policy. Asthma was identiﬁed as a
priority along with obesity, unintentional injury and
mental health. The overall aim of this systematic review
was to capture all of the literature associating early environ-
mental exposures and asthma development in children up
to 9 years of age; this cut-off was chosen to avoid the
effects of puberty and active smoking on asthma causation.
A recent paper describes associations between environ-
mental exposures and asthma control and exacerbation.11
Our speciﬁc aims were (1) to describe the magnitude of
association between the development of asthma and envir-
onmental exposures and (2) to explore evidence of inter-
actions between environmental exposures.
METHODS
Study design
A workshop attended by senior researchers from govern-
ment and academia, and health practitioners and policy
professionals identiﬁed environmental inﬂuences con-
sidered important on causation and exacerbation of
asthma (previously described,11 box 1). By extrapolation
from approaches to assessment of causation in work-
place exposures for compensation purposes (http://iiac.
independent.gov.uk/about/index.shtm), we considered
an exposure that increased the risk for asthma by at least
twofold as having at least a modest effect size.
Search strategy and data sources
The search strategy for MEDLINE is provided in the
online supplementary material and has also been
described previously.11 Two reviewers (SD and ED)
searched the electronic databases (including MEDLINE,
EMBASE, Cochrane controlled trials register (CCTR)
and CINHAL) and reference lists of other studies and
reviews between January 2010 and April 2010. Updated
searches were carried out in July 2011 and November
2013. No date limits were applied to the search strategy.
Studies identiﬁed from searching electronic databases
were combined, duplicates removed and papers were
screened for relevance to the review based on the infor-
mation contained in the title and abstract. Abstracts
were screened by a second reviewer (SWT) and poten-
tially eligible papers were identiﬁed.
Inclusion/exclusion criteria
Studies were included if (A) they captured exposure to an
environmental factor identiﬁed as potentially relevant to
the development of asthma; (B) the mean age of asthma
outcome was ≤9 years. (C) Outcomes include diagnosis of
asthma or data related to healthcare utilisation (hospital
admissions, drug use), (D) the study design was either a
meta-analysis, systematic review, randomised control trial,
non-randomised control trial or cohort study. If no evi-
dence was apparent for an exposure, then studies meeting
the lower Scottish Intercollegiate Guidelines Network
criteria were considered, that is, case–control and case
report studies (http://www.sign.ac.uk/guidelines/fulltext/
50/annexb.html 21 Jun 2014).
Study selection and data extraction
The full text of references identiﬁed as potentially rele-
vant was obtained and papers included by applying the
inclusion criteria, sometimes after discussion between
reviewers (SD and SWT). Papers that were included in a
systematic review were not included. For cohort studies
where outcomes were reported at increasing ages after
one exposure, only the most recent paper was included.
A summary table included the following details from
studies: study design, characteristics of the study popula-
tion, study objectives and the key outcome(s) reported
including what the primary asthma outcome was, for
example, wheeze, physician diagnosed asthma, etc.
Quality assessment
Quality assessment of included papers was carried out
using “Effective public health practice project quality
assessment tool for quantitative studies” (http://www.
ephpp.ca/PDF/Quality%20Assessment%20Tool_2010_2.
pdf accessed Jun 2014). Results are presented in the
online supplementary material; due to the relatively
large number of studies identiﬁed, a random 10% were
chosen for quality assessment.
RESULTS
Literature search
There were 14 691 references identiﬁed from electronic
databases and other studies. There were 207 full papers
reviewed and 135 studies met the inclusion criteria
(ﬁgure 1). There were 15 systematic reviews, 6
meta-analyses, 92 cohort studies, 14 intervention studies
included, 5 case–control studies and 3 cross-sectional
studies. No case series were included. There were 62
studies from Europe (including 3 meta-analyses), 32 from
North America, 13 studies from Australia or New
Box 1 Areas for environmental determinants of causation
and exacerbation of asthma derived from stakeholder
workshop
▸ Environmental tobacco smoke (antenatal and postnatal);
▸ Domestic combustion (cooking, heating and candles);
▸ Inhaled chemicals (volatile organic compounds, Chlorine,
phthalates);
▸ Damp housing/mould;
▸ Inhaled allergens (house dust mite, pets, pollens);
▸ Air pollution;
▸ Dietary exposures (maternal diet, breast feeding, diet in
childhood);
▸ Respiratory virus infection;
▸ Medications (antibiotics and paracetamol);
▸ Industrial combustion (incinerators);
▸ Fireworks and bonfires;
▸ Vacuuming;
▸ Air conditioning or humidifiers.
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Zealand, 3 from Japan and single remaining papers from
UAE, India, Qatar, South Korea, Mexico, Taiwan and
Brazil. There were 84 (63%) studies published in the past
5 years, that is, from 2009. Box 1 in the online supple-
mentary ﬁle presents details of the included studies,
including number and mean age of children included,
the respiratory outcome reported and the effect size. No
studies were identiﬁed for industrial combustion, ﬁre-
works, bonﬁres, vacuuming, air conditioning or air humi-
diﬁers. Table 1 presents the effect size of the exposures
on asthma risk from the studies identiﬁed. Table 2 pre-
sents results from studies where interactions between
exposures were associated with altered asthma risk
Secondhand smoke
Antenatal exposure
One meta-analysis and ﬁve cohort studies were identiﬁed
and most found exposure was associated with increased
risk for asthma. The meta-analysis12 identiﬁed 735
exposed children and concluded that exposure was asso-
ciated with an increased risk for asthma at 6 years (OR
1.7). The cohort studies found that risk was increased by
1.1313 and 2.114 at 2 years, and 1.4 at 7 years.15 One
study of infants born 3–4 weeks prematurely found
increased risk for wheeze at 3 years only among those
exposed to secondhand smoke (SHS; OR 4.0, table 2).16
One study found no association between antenatal
exposure and risk for symptoms.17
Postnatal exposure
One systematic review and six cohort studies were identi-
ﬁed and all reported that exposure was associated with
increased asthma risk. The systematic review concluded
that exposure to tobacco smoke was associated with an
increased risk of 1.3 among children aged 6–18 years.5
Postnatal exposure was associated with increased risk for
wheeze between 1.218 and 2.9,17 and 1.7 for asthma at
5 years (table 2).19 The study from Japan17 found a link
between postnatal but not antenatal maternal smoking
and wheeze at 16–24 months. One study18 found that
postnatal paternal smoking was a risk factor for wheeze
(RR 1.14 (1.04 to 1.24)) independent of maternal
smoking. Another study reported an interaction between
short duration of maternal education and SHS expos-
ure.19 A ﬁnal study found that increasing exposure to
ﬁne particulates (PM2.5) and urinary cotinine, products
of tobacco combustion, was positively linked to risk for
infant wheeze.20
Domestic combustion
Two cohort, one cross-sectional and two case–control
studies were identiﬁed and there was inconsistent evi-
dence between exposure and asthma risk. One cohort
study retrospectively modelled exposure to gas cooking
at 5 years to asthma in 4-year-olds and found no associ-
ation.21 In a second cohort study, increasing exposure to
domestic PM2.5 was associated with increased risk for
new onset wheeze over the next 3 years (OR 1.5 per
quartile increase in exposure), adjusting for SHS expos-
ure.22 A cross-sectional study found an association
between detectable indoor air sulfur dioxide (SO2) and
risk for wheeze (OR 1.8) at age 6–10 years.23 This study
found no link between burning incense and asthma
symptoms23 and this was consistent with a case–control
study that found no evidence for exposure to Bakhour
incense and risk for asthma.24 A case–control study from
India25 found evidence for increased asthma among
children (OR 4.3) living in homes where biomass was
used for cooking compared with other homes.
Inhaled chemicals
One meta-analysis, one cohort study, one cross-sectional
study and two reports from one case–control study were
identiﬁed and all found evidence of exposure being
associated with increased asthma risk. The meta-analysis
of data from seven studies concluded that increasing for-
maldehyde exposure was associated with increased
asthma risk (OR 1.2 per 10 µg/m3 increase).26 A cohort
study27 used redecoration of the apartment as a proxy
for exposure to volatile organic compounds (VOCs) and
found an increase in risk for obstructive bronchitis (OR
4.2). Simultaneous exposure to SHS and cats added to
the risk of obstructive bronchiolitis in the second year
(OR 5.1, table 2).27 One cross-sectional study28 found an
association between indoor exposure VOC of microbial
origin (MVOCs) and plasticisers, and risk of asthma
(mean increased risk for asthma 2.1/µg/m3 of total
MVOC). Two scientiﬁc papers on the same study29 30
found domestic exposure to formaldehyde, benzene and
its compounds, and toluene, was positively associated
with asthma risk (3% increase per 10 µg/m3 increase in
formaldehyde exposure).
Figure 1 QUOROM statement flow chart.
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Table 1 Magnitude of effect of environmental exposure on respiratory symptoms
Exposure Magnitude of effect (95% CI)
SHS
Antenatal exposure 1.7 (1.2 to 2.3)‡12
1.13 (1.04 to 1.23)*13
2.1 (1.2 to 3.7)†14
1.35 (1.13 to 1.62)†15
4.0 (1.9 to 8.6)*16
No association17
Postnatal exposure 1.3 (1.1 to 1.6)†‡5
1.2 (1.0 to 1.3)*18
2.9 (1.1 to 7.2)*17
1.7 (1.1 to 2.58)†19
4.2 (1.4, 13.0) for exposure to high fine particulate*20
Domestic combustion
Gas cooking No association21
Fine particulates (PM2.5) 1.5 (1.1 to 2.2) per quartile PM2.5 increase*
22
Detectable Sulfur Dioxide OR 1.8 (1.1 to 3.1)*23
Incense No association24 1723
Biomass 4.3 (3.0 to 5.0)†25
Inhaled chemicals
VOC 1.2 (1.01 to 1.4) per 10 µg/m3 increase†26
4.2 (1.4 to 12.9)¶27
2.1 (1.1 to 3.9) per µg/m3 of total MVOC*28
1.39 (no CI given)†29
2.92 (2.25 to 3.75)†30
Chlorinated swimming pools 0.5 (0.3 to 0.9)†31
No association ¥32
Other chemicals 1.7 (1.2 to 2.4)*34 (cleaning agents)
1.6 (1.2 to 2.1)†‡33 (PVC)
1.9 (1.1 to 3.2)†35 (pyrene)
0.7 (0.5 to 0.9)*36 (maternal BPA)
1.4 (1.0 to 1.9)*36 (child BPA)
2.8 (2.0 to 3.9)†37 and 1.7 (1.01 to 2.9)*38 (oil refinery)
Damp housing/mould 1.5 (1.3 to 1.7)†‡39
1.4 (1.1 to 1.8))*‡40 (no association at 6–8 years)
7.1 (2.2 to 12.6)†41
2.4 (1.1 to 5.6)†42 for exposure
2.6 (1.1 to 6.3)43 per unit increase in mould index
1.8 (1.5 to 22)44 per unit increase in mould index
Multiple exposures 0.7 (0.5 to 0.9)‡48
0.4 (0.3 to 0.8)‡49
3.0 (1.1 to 7.9) for high HDM† and 1.2 (1.1 to 1.4)* per quartile LPS increase50
1.8 (1.02 to 3.0)* increasing cockroach allergen55 and 0.3 (0.1 to 0.98)* for dog and 0.6
(0.4 to 1.01)* for cat exposure55
2.6 (1.3 to 5.4)† for high cat exposure51
2.7 (1.1 to 7.1)† dog and SHS to 4.8 (1.1 to 21.5)† dog and elevated NO2
56
3.1 (1.8, 5.2)* for exposure to SHS, infection and no breast feeding57
No association‡45‡ 46‡ 47 52–54
Inhaled allergens/particles
Pet 0.7 (0.6 to 0.9)†‡ cat exposure59
1.1 (1.0 to 1.3)†‡ dog exposure59
4.7 (1.2 to 18.0)† cat exposure61
0.6 (0.4 to 0.9)* cat exposure62
0.3 (0.1 to 0.81)* cat exposure63
1.2 (1.1 to 1.3)* cat exposure64
No association‡60 65 66
Other exposures 1.5 (1.1 to 2.1)* highest vs lowest quartile LPS exposure68
1.4 (1.1 to 1.7)* mouse allergen69
Continued
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Table 1 Continued
Exposure Magnitude of effect (95% CI)
0.4 (0.2 to 0.6)† feather quilt70
1.8 (1.0 to 3.2)† number of synthetic bedding items71
No association cockroach52
HDM No association‡72‡73 74
Outdoor allergens OR 3.1 (1.3 to 7.4)* birthday during fungal spore season75 OR 1.4 (1.1 to 1.7)† grass
pollen exposure76
RR 1.2 (1.02 to 1.3)† tree canopy cover77
Air pollution 1.05 (1.00 to 1.11)†‡ per ppm increased NO2
78
1.02 (1.00 to 1.04)†‡ per ppm increased NO78
1.06 (1.01 to 1.12)†‡ per ppm increased CO78
1.04 (1.01 to 1.07)*‡ per ppm increased SO2
78
1.05 (1.04 to 1.07)*‡ per unit increase particulates78
1.04 (1.01 to 1.07)* per ppm increased CO79
1.2 (1.0 to 1.31)† per 5ppb increase NO2
80
2.0 (1.2 to 3.6)† traffic-related particles82
1.3 (1.0 to 1.6)† higher traffic density84
3.1 (1.3 to 7.4)† high exposure to PM2.5
85
No association81
Dietary exposures
Maternal dietary components
during pregnancy
0.2 (0.08 to 0.6)†‡ Mediterranean diet86
0.6 (0.4 to 1.0)* Western diet88
0.6, (0.3 to 0.96)* fish consumption89
0.8 (0.7 to 1.0) peanuts and 0.8 (0.7 to 0.8) tree nuts†90
1.6 (1.2 to 2.0) low vegetables 1.5 (1.2 to 1.8) low fruit and chocolate 1.4 (1.1 to 1.7)†91
No association fish oil87‡, butter and margarine92
Specific nutrient intake during
pregnancy
0.6 (0.4 to 0.7)*‡ increased vitamin D intake86
0.7 (0.5 to 0.9)*‡ increased vitamin E intake86
0.3 (0.1 to 0.4)*‡ increased plasma vitamin A86
0.95 (0.91 to 0.99)* per 10 nmol/L increase cord vitamin D97
No association vitamin D (plasma)93–95 (intake)96, dietary antioxidants99 or folate100 or
vitamin A101 supplements
Breast feeding OR 0.92 (0.86 to 0.98)*‡102
OR 1.1 (1.0 to 1.2)†‡102
1.4 (1.2 to 1.7)* never breast feeding103
0.9 (0.8 to 0.96)† exclusive breast feeding104
2.0 (1.0 to 3.8)† maternal margarine intake during lactation98
No association‡105
Cow’s milk formula RR 0.4, (0.2 to 0.9)*‡ hydrolysed vs standard106
OR 0.3 (0.1 to 1.0)* fatty acid supplementation108
No association109
Infant diet 0.4 (0.2 to 0.9) for youngest vs oldest age at introduction of wheat†111
0.6 (0.4 to 0.9) for early vs delayed introduction of fish115
No association with age at introduction of solids112 113 prebiotic supplementation‡117
‡
118 or vitamin supplementation119
Child diet 0.6 (0.4 to 0.9)† full cream milk121
1.5 (1.04 to 2.1) Western diet124
0.93 (0.85 to 1.00) per fruit item consumption/day/week125
0.5 (0.3 to 0.6) for highest vs lowest tertile plasma vitamin D126
No association milk supplementation‡120, organic food122, dietary anti oxidant123
Respiratory virus infection
Respiratory infection±wheeze 0.5 (0.3 to 0.9)† for infant lower respiratory tract infection127
9.8 (4.3 to 22.0)* wheeze with rhinovirus128
2.9 (1.2 to 7.1)† wheeze with rhinovirus129
2.2 (1.5 to 3.3)† RSV infection 6–11 months previously130
0.9 (0.7 to 1.0)† early day care132
No association early day care131
Continued
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Chlorinated swimming pools
Two cohort studies were identiﬁed. Exposure to chlori-
nated swimming pools in infancy and childhood was
associated with reduced risk for current asthma at
7 years (OR 0.5).31 A second study found no link
between exposure to chlorine through swimming and
asthma at 6 years of age;32 those who did not attend
swimming during the ﬁrst year of life were more likely to
have asthma.
Other chemicals
In this broad category, there was one systematic review,
two cohort studies, two cross-sectional studies and a case–
control study; all found evidence of exposures being
linked to increased asthma symptoms. A systematic review
of seven studies of children aged up to 12 years found a
positive association between polyvinyl chloride exposure
in dust samples and asthma (OR 1.6).33 One study (using
the same cohort aforementioned31) created a composite
household chemicals exposure score (including chlor-
ine/chloride exposure), and found a positive association
between exposure and risk of incident wheeze after
2.5 years of age (OR 1.7).34 Two cohort studies related
antenatal and current exposures to asthma risk: high
exposure to pyrene was associated with increased asthma
risk in 5–6-year-olds (OR 1.9),35 and this association was
only apparent in non-atopic children, and maternal
exposure during pregnancy was not related to asthma
(table 2); maternal bisphenol A (BPA) exposure during
pregnancy was inversely associated with wheeze at 5 years
(OR 0.7) but not at 7 years; however, the child’s current
exposure was positively associated with this outcome (OR
1.4).36 Living close to a petrochemical plant was
associated with an increased risk for asthma (OR 2.8).37
A case–control study found increased wheeze in
6–14-year-olds living close to an oil reﬁnery compared
with controls (OR 1.7).38
Damp housing/mould
One systematic review, one meta-analysis plus four cohort
studies were identiﬁed and early exposure was consist-
ently associated with increased risk for later asthma symp-
toms. The systematic review included data from 16 studies
and concluded that exposure to visible mould was asso-
ciated with increased risk for asthma (OR 1.5).39 The
meta-analysis of eight European birth cohorts found an
association between exposure to visible mould or damp-
ness and increased wheeze at 2 years (OR 1.4) but this
was not signiﬁcant at 6–8 years (OR 1.1).40 The cohort
studies found mould exposure in early life to be asso-
ciated with increased risk for asthma at 3 years (OR 7.1)41
and 7 years (RR 2.4 for presence of any mould,42 and OR
of 2.643 and 1.844 per unit increase in mouldiness index).
Inhaled allergens
Indoor exposures
Multiple exposures: There were ﬁve intervention studies
and eight cohort studies identiﬁed. One intervention
randomised newborns to house dust mite (HDM) reduc-
tion measures, avoidance of cow’s milk or both or
neither and found no difference in asthma incidence at
age 5 years across the four groups.45 A second study also
modiﬁed postnatal exposure to cow’s milk protein (and
other dietary allergens) and HDM and the intervention
group had trends for reduced wheeze (OR 0.4 (0.2 to
1.08)) at 8 years.46 A third intervention study reduced
exposures to SHS, inhaled and ingested allergens and
promoted breast feeding but found no difference in
asthma outcome age 6 years.47 The fourth intervention
modiﬁed exposures to antenatal and postnatal oily ﬁsh,
Table 1 Continued
Exposure Magnitude of effect (95% CI)
Medications
Antibiotics 1.2 (1.0 to 1.5)†‡ antenatal exposure135
1.5 (1.3 to 1.8)†‡ postnatal exposure135
No association†‡136
Paracetamol 1.3 (1.1 to 1.4)†‡139
1.2 (1.0 to 1.4)*‡138
No association140
Other medications 1.1 (1.0 to 1.2) for antibiotics, 1.3 (1.1 to 1.6) gastro-oesophageal reflux treatment, 1.6
(1.1 to 2.3) opiates, 1.3 (1.2 to 1.4) thyroid supplements140
Other maternal exposures during
pregnancy
2.7 (1.2 to 6.0)* dietary dioxins and polychlorinated biphenyl141
2.3 (1.3 to 4.1)* highest vs lowest BPA exposure142
0.7 (0.5 to 0.9)* BPA exposure36
1.1 (1.0 to 1.2)* per 10% increase in DDT metabolite143
1.2 (1.0 to 1.3) for increasing electromagnetic exposure144
No effect size and/or confidence intervals were identified for studies with the following citations: 58, 67, 83, 107, 110, 114, 116 and 137.
Magnitude of effect of environmental exposure on respiratory symptoms including wheeze (*), asthma (†), obstructive bronchitis (¶) or atopic
disease (¥) in children aged up to 9 years. Details of when the exposure occurred are presented in the text and the supplemental table.
‡Indicates a randomised clinical trial, systematic review or meta-analysis.
BPA, bisphenol A; DDT, dichlorodiphenyltrichloroethane; HDM, house dust mite; LPS, lipopolysaccharide; MVOC, VOC of microbial origin;
PVC, polyvinyl chloride; RSV, respiratory syncytial virus; SHS, secondhand smoke; VOC, volatile organic compound.
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SHS and dampness and observed reduced asthma risk at
2 years for the intervention group (OR 0.7).48 The ﬁfth
study modiﬁed antenatal and postnatal exposures to
HDM, pets, SHS, promoted breast feeding and delayed
weaning, and asthma risk at 7 years was reduced in the
intervention group (OR 0.4).49 Five observational
studies related early life HDM exposure plus other ‘dust’
exposures to asthma: increased HDM and lipopolysac-
charide (LPS) exposures were independently associated
with increased symptoms by 7 years; HDM ≥10 µg/g was
associated with increased risk for asthma (OR 3.0) and
each quartile increase in LPS was associated with
increased risk for lifetime wheeze (OR 1.2).50 Exposure
to higher concentrations of cat allergen (but not HDM)
was associated with increased asthma risk by 6 years of
age OR for third versus lowest exposure quartile 2.6 (1.3
to 5.4);51 other studies found no association between (1)
infantile exposure to HDM and cat and cockroach
allergen and wheeze at 2 years,52 (2) HDM, cat and dog
allergen exposure and wheeze at 4 years,53 and (3)
HDM and cat exposure and asthma at 7 years.54 One
study reported increasing cockroach allergen exposure
in infancy was positively associated with wheeze by age
5 years (OR 1.8) and, independently, the presence of a
dog and higher concentrations of cat allergen exposure
were associated with reduced wheeze risk (OR 0.3 and
0.6).55 Dog allergen exposure in infancy was not asso-
ciated with asthma at 7 years per se but was associated
with asthma in combination with exposure to SHS (OR
2.7) or elevated NO2 (OR 4.8).
56 A ﬁnal study observed
interactions between exposures to SHS, breast feeding
and recurrent respiratory infections and asthma.57
Pet exposure: There were two systematic reviews, one
meta-analysis and six cohort studies identiﬁed and the
results were highly inconsistent. One systematic review of
nine studies concluded that exposure to pets around the
Table 2 Magnitude of effect of main effect on asthma aetiology and magnitude of interaction with other factor
Study Interaction between Magnitude of interaction (95% CI)
Robison et al16 Late premature delivery (<37 weeks)
and antenatal SHS exposure
OR for wheeze 2.0 (1.3 to 3.1) associated with prematurity and 1.1
(0.5 to 2.4) with in utero SHS exposure. OR for wheeze 3.8 (1.8 to
8.0) if both premature and SHS exposed
Martinez et al19 Smoke exposure from mother OR 2.6 (1.4 to 4.6) if exposed and mother ≤12 years education
OR 1.7 (1.1 to 2.6) for asthma by 5 years
Diez et al27 Redecoration
Pet exposure
Dampness
Redecoration associated with OR for obstructive bronchiolitis at
2 years 4.1 (1.4 to 12.9). OR 5.1 (1.6 to 15.6) if also exposed to
ETS or pets
Jung et al35 Pyrene exposure
Atopy
High exposure was associated with increased risk for asthma 1.9
(1.1 to 3.2) and this was increased to 2.9 (1.8 to 5.7) among
non-atopic children
Carlsten et al56 Dog exposure
SHS
High NO2
No association with dog exposure per se
OR 2.7 (1.1 to 7.1) for dog and SHS
OR 4.8 (1.1 to 21.5) for dog plus high NO2
Karmus et al57 Recurrent lower respiratory tract
infection
Breast feeding
SHS
OR 2.5 (1.8 to 3.4) for asthma at ages 4 and 10 years. OR 3.1 (1.8
to 5.2) with antenatal exposure to products of tobacco smoke
Melen et al61 Smoke exposure
Pets
Window pane condensation
OR for 1 to 2 and 3 exposures (compared to none) were 1.1, 4.4
(1.0 to 18.6) and 10.8 (2.0 to 59.6)
Celedon et al62 Early cat exposure
Maternal asthma
Exposure associated with reduced risk for wheeze (OR 0.6 (0.4 to
0.9)) but only in those with no maternal asthma
Trevillian et al71 Synthetic bedding
Bedroom heating
Recent bedroom painting
Exposure to >1 synthetic item of bedding was associated with
increased asthma (OR 1.8 (1.0 to 3.2)). Co-exposure to room
heating was associated with OR 7.1 (0.1 to 23.9), recent painting
OR 7.2 (2.3 to 23.2)
Kim et al81 Ambient air pollution (ozone, CO,
NO2, SO2 and PM10)
Previous bronchiolitis
Asthma at 5 years not associated with higher exposures but among
bronchiolitis subset ozone exposure associated with OR 7.5 (2.7 to
21.3), CO exposure OR 8.3 (2.9 to 23.7) and NO2 exposure OR
7.9 (0.97 to 64.8)
Ryan et al82 Traffic-related particles (elemental
carbon attributable to traffic)
Domestic LPS
A positive asthma predictive index at 36 months was associated
with exposure to increased levels of particles before 12 months
(OR=2.0 (1.2 to 3.6)). Co-exposure to high concentrations of
endotoxin increased the risk (OR=3.4 (1.3 to 8.9))
Kusel et al129 Atopy
Virus positive wheezing illness
OR 3.1 (1.5 to 6.4) if atopic for wheeze at 5 years. OR 3.9 (1.4 to
10.5) if also wheezy illness
LPS, lipopolysaccharide; SHS, secondhand smoke.
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time of birth may reduce risk for allergic disease (includ-
ing asthma) where there is no family history of asthma,
but no effect size was given.58 The second systematic
review concluded that exposure to cats reduced the risk
for asthma (OR 0.7) and to dogs increased asthma risk
(OR 1.1).59 The meta-analysis found no evidence for cat
exposure in early life being linked to asthma risk at age
6–10 years; there was a non-signiﬁcant trend for dog
ownership to be associated with reduced asthma risk
(OR 0.8 (0.6 to 1.0)).60 The cohort studies found early
cat exposure to be associated with increased severe
asthma at 4 years (OR 4.7),61 and reduced wheeze by
age 5 years (OR 0.662 and 0.363), increased wheeze at
7 years (OR 1.2)64 and no association with asthma risk at
465 or 8 years;66 in a post hoc analysis, early exposure to
dog was linked to reduced late onset wheeze at 4 (OR
0.4 (0.2 to 1.0)).65 There was apparent synergy between
exposure to high concentrations of cat allergen, SHS
exposure and window pane condensation and increased
risk for severe asthma at 4 years (OR 10.8 (2.0 to
59.6)).61
Other exposures: There was one systematic review iden-
tiﬁed relating exposure to farm living to asthma risk; data
from 39 studies were identiﬁed, and despite differences
in deﬁnitions for asthma and associations with exposure
to living on a farm, there was a 25% reduction in risk of
asthma for children living on a farm compared with con-
trols (no CIs presented).67 A cohort study found an asso-
ciation between LPS concentration in mother’s mattress
when the infant was 3 months old and repeated wheeze
by 2 years of age (OR 1.5 comparing highest with lowest
quartile for exposure).68 A second cohort study reported
an association between increased current exposure to
mouse allergen and wheeze at 7 years of age (OR 1.4)69;
there was no association between mouse allergen expos-
ure in infancy and later wheeze. A third small cohort
reported no association between exposure to cockroach
allergen in infancy and wheeze in the ﬁrst 2 years of
life.52 Observational studies report associations between
exposure to feather quilt in infancy and reduced asthma
at 4 years compared with non-feather quilt (OR 0.4)70
and that a greater number of synthetic items of bedding
(known to be HDM rich) during infancy was associated
with increased risk for a history of asthma by 7 years (OR
1.8).71
HDM exposure: There were two intervention studies72 73
and one observational study,74 and none found an associ-
ation between exposure in infancy72 73 or by 2 years of
age74 and asthma at 3,73 6–774 or 8 years of age.72
Outdoor allergens: Three cohort studies were identi-
ﬁed and all found exposure was related to increased
asthma risk. One study related fungal spores and pollen
concentrations at the time of birth to wheeze at age
2 years and those born in autumn to winter (the fungal
spore season) were at increased risk for wheezing (OR
3.1).75 A second study reported an association between
increased grass pollen exposure between 4 and 6 months
of age and increased asthma at 7 years of age (OR 1.4).76
The third study related tree canopy cover (a source of
tree pollen and also of altered airﬂow and air quality) in
infancy to asthma at 7 years and found a positive associ-
ation (RR 1.2).77
Air pollution
One meta-analysis and eight additional cohort studies
were identiﬁed, and while pollutants associated with
combustion were associated with increased asthma risk,
no single pollutant was consistently identiﬁed. The
meta-analysis found that exposure to Nitrogen Dioxide
(NO2, OR 1.05), Nitric Oxide (OR 1.02) and Carbon
Monoxide (CO, OR 1.06) were associated with higher
prevalence of diagnosis of childhood asthma. Exposures
to SO2 (OR 1.04) and particulates (OR 1.05) were asso-
ciated with a higher prevalence of wheeze in children.78
Ambient lifetime CO exposure, but not NO2, ozone or
particulates with mass less than 2.5 microns (PM2.5), was
associated with increased risk for wheeze at 5 years (OR
1.04 per ppm increased CO).79 A second cohort study
found that ambient exposure to NO2, but not ozone,
SO2, PM2.5 and PM10, was associated with increased
asthma risk at 3 years (OR 1.2 per 5ppb increase).80 A
third study related averaged lifetime exposure to ozone,
CO, NO2, SO2 and PM10, and found no association with
asthma in 7-year-olds for the whole population, but
among the 10% with previous bronchiolitis, asthma risk
was increased (OR approximately 7) in association with
higher exposures to ozone, CO and NO2 (table 2).
81
Exposure to trafﬁc-related particles (elemental carbon
attributable to trafﬁc) during infancy was associated with
increased risk for asthma in 3-year -olds (OR 2.0) and
co-exposure to high concentrations of domestic endo-
toxin increased the risk (OR 3.4).82 One study found
increased wheeze prevalence in 4-year-olds among those
exposed to stop/go trafﬁc compared with unexposed
children (23% vs 11%)83 and the second found that
children with a lifetime exposure to higher trafﬁc
density were more likely to be diagnosed with asthma
(OR 1.3).84 Exposure to high (>4.1 µg/m3) levels of
PM2.5 during infancy were associated with increased risk
for asthma in a small cohort (OR 3.1).85
Dietary exposures
Maternal diet—food items
There was one systematic review, one intervention study
and ﬁve cohort studies identiﬁed, and some food items
were linked to childhood asthma risk. The systematic
review of 62 studies concluded that there was more convin-
cing evidence for maternal fruit (compared with vege-
table) intake during pregnancy to be associated with
reduced risk for childhood asthma;86 there was only one
study that identiﬁed maternal Mediterranean diet to
outcome (persistent wheeze (OR 0.2) at age 6.5 years) and
maternal exposure to ﬁsh was not included. A small inter-
vention study where pregnant mothers took placebo or ﬁsh
oil supplement found no difference in respiratory symp-
toms between treatment groups at 1 year.87 A study from
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Japan found reduced risk for wheeze at 16–24 months for
children whose mother’s diet had been least ‘Westernised’
(OR 0.6 for comparison with most ‘Westernised’).88 A
Mexican study found a protective effect of ﬁsh consump-
tion during pregnancy on atopic wheeze (OR 0.6).89 In
Denmark, maternal intake of peanuts (OR 0.8) and tree
nuts (OR 0.8) was inversely associated with asthma in chil-
dren at 18 months of age.90 In Finland, low maternal con-
sumption of leafy vegetables (OR 1.6), malaceous fruits
(eg, apple, pear, OR 1.5) and chocolate (OR 1.4) were
positively associated with the risk of wheeze in 5-year-old
children.91 A ﬁnal study found no association between
maternal butter and margarine intake and asthma out-
comes in children aged 5–6.92
Maternal diet-specific nutrients
There was one systematic review and eight cohort studies
identiﬁed, and reduced exposure to some nutrients was
associated with increased asthma risk. Meta-analysis
within the systematic review found that (1) increasing
maternal vitamin D intake was associated with reduced
risk for wheeze in the last year (OR 0.6, 4 studies) but not
asthma at 5 years; (2) increasing maternal vitamin E
intake was associated with reduced wheeze at 2 years (OR
0.7, 3 studies); (3) increased maternal plasma vitamin A
was associated with reduced asthma risk (OR 0.3, 2
studies); and (4) there was no evidence for associations
between maternal plasma zinc or selenium and asthma
outcomes.86 Of ﬁve cohort studies published after the sys-
tematic review, four found no evidence linking maternal
plasma vitamin D93–95 or vitamin D intake96 and asthma;
one study found an inverse association between cord
plasma vitamin D and risk for wheeze, but not asthma, by
age 5 years (OR 0.95 per 10 nmol/L increase).97 One
study found maternal fatty acid intake during the third
trimester was associated with asthma outcome at 5 years
(eg, higher α-linoleic acid and palmitic acid intake asso-
ciated with ∼40% reduced risk).98 Other studies found
no association between maternal dietary antioxidants99
or folate100 and vitamin A101 supplementation and child-
hood asthma outcomes.
Exposure to milk during infancy
In addition to the previously described complex inter-
ventions where milk exposure was modiﬁed, a number
of studies were identiﬁed where only milk was the expos-
ure of interest and there was evidence that early milk
exposure was related to altered asthma risk.
Breast milk: One systematic review with meta-analysis,
two cohort studies and one intervention study were iden-
tiﬁed. Meta-analysis of 31 studies found any breast
feeding reduced risk for wheeze (OR 0.92) but
increased risk for asthma (OR 1.10).102 Never breast
feeding was associated with increased wheeze by 4 years
(OR 1.4)103 and exclusive breast feeding was associated
with reduced asthma risk at 5 (OR 0.9)104 but not at
6 years of age. The intervention study found that pro-
longed breast feeding (up to the age of 12 months) was
associated with reduced asthma at 4 but not at 6 years of
age.105 Maternal margarine intake (but not fatty acid or
ﬁsh intake) while breast feeding was associated with
increased risk for asthma at 5 years (HR 2.0).98
Cow’s milk formula: One systematic review, two interven-
tion studies and one observational study were identiﬁed.
A systematic review of 10 trials concluded that hydro-
lysed cow’s milk formula, but not soya-based milk,
reduced risk of wheezing in infancy (RR 0.4) compared
with standard cow’s milk formula.106 Modiﬁcation of
cow’s milk formula either by a non-hydrolysing fermen-
tation process or supplementation with fatty acids (ara-
chidonic acid or docosahexaenoic acid) was associated
with reduced risk for wheeze by 2 (13% vs 35%)107 and
3 years of age (OR 0.3)108 compared with standard cow’s
milk formula. An observational study found no evidence
for hydrolysed feed for the ﬁrst 6 months reducing
asthma risk at 3 years.109
Dietary exposures during infancy
There were two systematic reviews, two clinical trials and
ﬁve observational studies identiﬁed; there were some
associations between exposure to some dietary compo-
nents and altered risk reported. Four observational
studies related ﬁrst dietary exposures to asthma out-
comes, and one found evidence for early introduction of
cereals by 6 months, and egg by 11 months was associated
with 30–40% reduced risk for asthma at 5 years,110 and a
second study found a direct relationship between age at
introduction of oats and risk for asthma at 5 years (OR
0.4 for earliest vs latest age at introduction).111 Two other
studies found no association between early or delayed
introduction of any solids and asthma risk at 5112 and 6
years.113 A systematic review of 14 studies relating ﬁsh oil
exposure during infancy and asthma (and other allergic
outcomes) concluded that exposure was linked to a
reduced risk of between 5% and 75%.114 One cohort
study found an association between the introduction of
ﬁsh between 6 and 12 months and decreased risk for
wheezing at 48 months (OR 0.6);115 however, the two pre-
viously discussed studies found no association between
ﬁsh exposure and asthma112 113 and an intervention
study of ﬁsh oil supplements in the ﬁrst 6 months of life
did not change risk for asthma symptoms at 12
months.116 A systematic review of two trials found no link
between infant diet supplementation prebiotics and
asthma risk,117 and a trial where infants were randomised
to supplement with probiotic (±prebiotic) or placebo
also found no difference in asthma risk.118 One cohort
study found no evidence for association between infant
vitamin supplements and asthma risk, although among
African–Americans, supplementation was associated with
increased risk (OR 1.3).119
Dietary exposure in childhood
One RCT and six cohort studies were identiﬁed, and
there was limited evidence linking early exposure to later
increased asthma risk. Supplementation of milk with
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fermented milk containing lactobacillus during the ﬁrst
2 years did not alter risk for asthma compared with
placebo.120 One observational study found daily exposure
to full cream milk at 2 years reduced risk for asthma
1 year later (OR 0.6 (0.4 to 0.9)).121 Exposure to organic
food during the ﬁrst 2 years122 and dietary oxidant at 5123
were not associated with altered risk for wheeze at 2 years
or asthma at 8 years, respectively. Studies from the
Netherlands found exposure to a ‘western’ diet at
14 months was associated with an increased risk for fre-
quent wheeze at 3 years (RR 1.5),124 exposure to fruit in
early childhood reduced risk for asthma at 8 years (OR
0.93 per item consumed day per week)125 and that
increased plasma vitamin D at 4 years was associated with
reduced asthma risk at 8 years (OR for highest vs lowest
tertile 3 0.5)126 but serum vitamin D levels at 8 years were
not associated with current asthma risk.126
Respiratory virus infection
There were six cohort studies identiﬁed and there was
consistent evidence for infection associated with wheeze
or that hospitalisation increased asthma risk. Parent
reported lower respiratory tract infections during
infancy were negatively associated with the risk of
asthma at 7 years of age in one cohort (OR 0.5).127 A
cohort study demonstrated that wheeze before 4 years of
age was associated with increased risk for asthma at
6 years if rhinovirus (OR 9.8) was present;128 there was a
borderline increase in risk if respiratory syncytial virus
(RSV) was present (OR 2.6). A second cohort selected
for familial risk for atopy also found rhinovirus positive
(but not RSV positive) wheezing lower respiratory tract
infection during infancy was associated with increased
risk for asthma at age 5 years (OR 2.9).129 A third study
observed an increased risk of asthma following infection
with RSV, and this risk was higher in the months follow-
ing the hospitalisation and lower with longer duration
since hospitalisation (eg, RR 6.2 within 2 months of hos-
pitalisation and RR 2.2 6–11 months after hospitalisa-
tion).130 Early daycare, a proxy for respiratory infections,
was not associated with altered risk for asthma at age 8
years131 in one cohort but was associated with reduced
asthma risk at 8 years in a second study (HR 0.9).132
Other infections
One small cohort study observed reduced risk for wheeze
at 18 months for children whose parents cleaned their
dummy/paciﬁer by sucking it (OR 0.1 (0.01 to 1.0)) com-
pared with other cleaning practices.133 A second cohort
study found no evidence for infection in preschool chil-
dren (either serologically proven or isolated from stool
samples) and wheeze by 11 years.134
Medications
Antibiotics
Three systematic reviews were identiﬁed that related
antenatal135 and postnatal135–137 exposure to antibiotics
and asthma outcomes. There was evidence that
antenatal and postnatal exposures were associated with
increased risk for early asthma symptoms (eg, OR 1.2 for
antenatal exposure and 1.5 for postnatal exposure)135
but all three systematic reviews concluded that this asso-
ciation was explained by reverse causation. One system-
atic review demonstrated that the OR fell from 1.3 to 1.1
when reverse causation was considered.136
Paracetamol
Three systematic reviews were identiﬁed and these linked
antenatal138 and postnatal137–139 exposure to paraceta-
mol to the risk of asthma symptoms. There were associa-
tions between paracetamol exposure and the
development of asthma OR 1.3139 and wheeze OR 1.2.138
The third systematic review did not present an effect size
and suggested that any association was by reverse
causation.137
Other maternal exposures during pregnancy
A whole-population study found treatment during the
second and third trimester with the following were asso-
ciated with increased risk for asthma: antibiotics
(OR 1.1); drugs for gastro-oesophageal reﬂux (OR 1.3);
opiates (OR 1.6); and thyroid drugs (OR 1.3). There was
no association with paracetamol prescribing.140 Five
cohort studies related various maternal exposures during
pregnancy to early childhood wheeze and reported the
following associations: exposure to dietary dioxins and
polychlorinated biphenyls was associated with increased
wheeze by 3 years (OR 2.7);141 exposure to BPA was posi-
tively associated with a transient increase in wheeze in
one study (OR for wheeze at 6 months 2.3, highest vs
lowest exposure)142 and inversely associated with transi-
ent wheeze in a second study (OR for wheeze at 5 years
0.7 per increase in log transformed BPA)36; each 10%
increase in exposure to dichlorodiphenyldichloroethy-
lene (a product of the pesticide dichlorodiphenyltrichlor-
oethane (DDT)) was associated with increased wheeze at
12–14 months of age (RR 1.11);143 each unit increase in
in utero electromagnetic exposure was linked with
increased risk for asthma at 13 years (HR 1.15).144
DISCUSSION
The aim of this systematic review was to provide an over-
view of the literature describing associations between
environmental exposures in early life and asthma out-
comes by 9 years of age. This review is mostly based on
observational studies and is likely to be inﬂuenced by sub-
mission bias (where investigators do not submit papers
that ﬁnd no associations which challenge current para-
digms) and/or publication bias. In addition, reverse caus-
ation or confounding may explain some associations
reported, for example, postnatal exposures to antibiotics,
paracetamol and perhaps pets. Moreover, observational
studies cannot prove causation and most intervention
studies found no effect on outcome even where studies
indicated a potentially important mechanism, for
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example, HDM interventions. Given these caveats, we
believe that three major conclusions can be drawn. First,
there was a moderately strong level of evidence (ie, RCT,
systematic review or meta-analysis) for the presence of
associations between most exposures and asthma risk but
the literature remains relatively deﬁcient for exposures to
infection and domestic combustion (both of which are
likely to be important on a global basis). Second, where
associations were present, these were of small-moderate
effect size by our predeﬁned standard. Third, we identi-
ﬁed interactions between exposures (most commonly
SHS) and/or atopy which increased the risk of that
exposure being associated with asthma. Given that there
is no prospect of a cure for asthma, modiﬁcation of the
environment in early life currently offers the best hope of
reducing the burden of asthma in the population and an
overview of all exposures such as we present here may be
of use to policymakers, healthcare workers and lobbying
groups.
There is no single exposure which seems likely to cause
asthma and even ‘single’ exposures are invariably con-
taminated by other exposures. There was consistent evi-
dence in the literature for associations between
exposures to SHS, inhaled chemicals, mould, respiratory
viruses, ambient air pollutants and maternal dietary com-
ponents, and increased asthma risk. However, each of
these is a complex exposure and there was evidence of
interaction between all these exposures. There is evi-
dence that asthma risk may be related to diversity of
exposure to fungus and not exposure per se145 and our
ﬁndings are consistent with this idea. There were incon-
sistent associations between asthma and exposures to
pets, breast feeding and infant diet when considered sep-
arately but those intervention studies where asthma risk
was successfully reduced often included modiﬁcations to
some or all of these exposures. There is further evidence
that asthma risk can be reduced by early exposure to an
environment that is diverse in many inhaled and ingested
factors common to the human environment for millen-
nia, such as animal dander, LPS, fungi and breast milk
(but not including man-made chemicals).
There are a number of limitations to this systematic
review in addition to those already described. First, in
the absence of a gold standard deﬁnition of asthma, dif-
ferent outcomes have been used, for example, asthma
or wheeze; these may not be interchangeable and have
different associations with a given exposure. Second,
associations reported may not be persistent: exposure to
breast feeding is an example of a waning effect of a
given exposure over time, presumably as current expo-
sures modify the effect of past exposures. Third, the
upper age of study participants was 9 years and this
meant that many highly cited studies describing associa-
tions between exposure and asthma risk in older chil-
dren were not included.146 Fourth, in our methodology
we included only the latest paper from cohorts where
associations may have been reported at several different
ages and this will mean that transient associations are
not captured; for example, we have interpreted an inter-
vention study where breast feeding was successfully pro-
longed as having no effect on asthma at 6 years105 but
the exposure was associated with reduced asthma symp-
toms in this cohort at ages 2147 and 4148 years. Finally, it
is possible that a given exposure may have a different
effect on asthma risk between populations where differ-
ent genetic and/or epigenetic factors may be acting.
In summary, we have reviewed the literature for asso-
ciations between all environmental exposures and the
development of asthma in children aged under 9 years.
Early life exposures to exhaled tobacco smoke, VOCs,
mould, breast feeding, pets and many dietary factors
appear to be important to the development of asthma
and interactions between these exposures further
increase this risk, particularly in individuals with allergic
parents. Complex interventions in early life are challen-
ging149 but the evidence in the observational literature
and from small intervention studies demonstrates that
approaches using this study design may lead to stronger
public health advice stating that interventions which
alter multiple early life environmental encounters are
able to modify asthma risk in this age group.
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